AstraZeneca开始在弗吉尼亚工厂生产4.5B美元,用于治疗癌症、糖尿病和重药,创造了600个工作机会。 AstraZeneca starts $4.5B Virginia plant for cancer, diabetes, and weight drugs, creating 600 jobs.

AstraZeneca已开始在弗吉尼亚州Albemarle县建造一个价值45亿美元的制药综合体,创造600个长期就业机会和3 000个建筑职位。 AstraZeneca has begun construction on a $4.5 billion pharmaceutical manufacturing complex in Albemarle County, Virginia, creating 600 permanent jobs and 3,000 construction positions. 该设施在夏洛茨维尔和里瓦纳站军事基地附近,将生产用于体重管理、代谢性疾病和癌症的药品,包括口服GLP-1和抗体药物共产物。 The facility, near Charlottesville and the Rivanna Station military base, will produce drugs for weight management, metabolic diseases, and cancer, including oral GLP-1s and antibody-drug conjugates. 该项目是到2030年美国500亿美元投资的一部分,得到970万美元国家赠款的支持,旨在加强中弗吉尼亚州的国内毒品制造和生物技术创新。 The project, part of a $50 billion U.S. investment by 2030, is supported by a $9.7 million state grant and aims to strengthen domestic drug manufacturing and biotech innovation in Central Virginia.